Elevated triglyceride levels (hypertriglyceridaemia) are among the most common blood lipid disorders and are a recognised risk factor for cardiovascular disease. Estimates suggest that up to 25% of adults in Western countries have triglyceride levels above 150 mg/dL — the threshold above which cardiologists consider levels elevated. Omega-3 fatty acids from marine sources (EPA and DHA) are one of the most thoroughly researched non-pharmacological approaches to lowering elevated triglycerides. EFSA has approved an official health claim for this, and the American Heart Association (AHA) confirmed the evidence in a Science Advisory. This article explains what the data truly shows — and what you need to know in practice.
What Are Triglycerides and Why Are Elevated Levels a Problem?
Triglycerides are the most common form of dietary fat and serve as an energy store. They are produced in the liver (from excess carbohydrates and alcohol) and released into the bloodstream via VLDL particles. After meals, triglyceride levels rise physiologically and fall again after fasting — which is why measurement should always be taken fasting (at least 8–12 hours without food).
Classification of Triglyceride Levels
According to the guidelines of the European Society of Cardiology (ESC) and the National Cholesterol Education Program (NCEP), the following thresholds are used:
- Normal: < 150 mg/dL (< 1.7 mmol/L)
- Borderline high: 150–199 mg/dL
- High: 200–499 mg/dL (hypertriglyceridaemia)
- Very high: ≥ 500 mg/dL (severe hypertriglyceridaemia, pancreatitis risk)
Chronically elevated triglyceride levels are associated with atherosclerosis, coronary artery disease and metabolic syndrome. At very high levels (≥ 500 mg/dL), there is also a risk of acute pancreatitis — a medical emergency.
The EFSA Health Claim: Normal Triglyceride Levels
The European Food Safety Authority (EFSA) has, after thorough review of the scientific evidence, approved the following health claim for EPA and DHA: EPA and DHA contribute to the maintenance of normal triglyceride concentrations in the blood. This claim applies from a minimum dose of 2,000 mg (2 g) EPA+DHA per day.
EFSA Health Claim: Triglyceride Levels
According to EFSA, EPA and DHA contribute to the maintenance of normal triglyceride concentrations in the blood. Approved minimum dose: 2,000 mg EPA+DHA per day. Foods or supplements may carry this claim if they contain at least 2 g EPA+DHA per daily serving. (EU Regulation No. 432/2012)
The basis for this claim is an extensive literature review of hundreds of clinical studies. The triglyceride effect of omega-3 is, alongside the heart health claim, one of the most scientifically robust findings in omega-3 research — and the only effect for which the FDA in the United States has approved prescription high-dose omega-3 preparations (Vascepa, Lovaza).
The 2019 AHA Science Advisory: Over 30% Reduction at 4 g/Day
The most influential current document on omega-3 triglyceride reduction is the AHA Science Advisory from 2019, authored by Skulas-Ray et al. and published in the journal Circulation. This official statement from the American Heart Association summarises the entire clinical evidence and provides clear recommendations.
Key Statements of the AHA Science Advisory
At a dosage of 4 g/day EPA+DHA (either as combined EPA+DHA or as pure EPA), studies show:
- In severe hypertriglyceridaemia (≥ 500 mg/dL): triglyceride reduction of 30–50%
- In moderate hypertriglyceridaemia (200–499 mg/dL): reduction of 20–30%
- In mildly elevated levels (150–199 mg/dL): reduction of 10–20%
The AHA Advisory states: "Omega-3 fatty acids are the most potent available agents for lowering very high triglyceride levels." This statement underscores the clinical relevance — especially in a range where lifestyle measures alone often prove insufficient.
AHA Recommendation: Triglyceride Reduction by Omega-3 at 4 g/Day
The American Heart Association confirmed in its Science Advisory: at 4 g/day EPA+DHA, triglycerides were reduced by 30–50% in severe hypertriglyceridaemia. In moderate hypertriglyceridaemia (200–499 mg/dL), reduction was 20–30%. The AHA recommends prescription omega-3 (4 g/day) as second-line therapy after statins for patients with persistent hypertriglyceridaemia. The Advisory also supported cardiovascular risk reduction (referencing REDUCE-IT data).
Mechanisms: Why Do EPA and DHA Lower Triglycerides So Effectively?
The triglyceride-lowering effect of omega-3 is one of the best-understood metabolic effects of these fatty acids. Several molecular mechanisms work together:
Inhibition of Hepatic VLDL Synthesis
The most important mechanism: EPA and DHA inhibit the production of VLDL particles (Very Low-Density Lipoprotein) in the liver, which transport triglycerides into the bloodstream. They activate the transcription factor PPARalpha (peroxisome proliferator-activated receptor alpha), which upregulates gene expression for fatty acid oxidation while simultaneously reducing lipogenesis (new fatty acid synthesis).
Enhancement of Beta-Oxidation
EPA and DHA promote the combustion of fatty acids in the mitochondria (beta-oxidation). More fatty acids are used as energy instead of being packaged into triglycerides and released into the blood. This effect is especially pronounced in the liver, but also plays a role in skeletal muscle.
Reduction of Lipogenesis
EPA and DHA inhibit the transcription factor SREBP-1c (sterol regulatory element-binding protein 1c), which is responsible for new fat synthesis from carbohydrates (de novo lipogenesis). Less de novo lipogenesis means fewer newly formed triglycerides in the liver.
Enhancement of LPL Activity
Lipoprotein lipase (LPL) is an enzyme in the vascular system that breaks down triglycerides from VLDL particles. EPA and DHA increase LPL activity — allowing circulating triglycerides to be removed from the blood more quickly.
Overview: Triglyceride Level and Expected Reduction with Omega-3
| Baseline (fasting) | Classification | Reduction at 2 g/day | Reduction at 4 g/day | Clinical relevance |
|---|---|---|---|---|
| < 150 mg/dL | Normal | Minor (< 10%) | 10–20% | Low (baseline supply) |
| 150–199 mg/dL | Borderline high | 10–15% | 15–25% | Moderate (prevention) |
| 200–499 mg/dL | High (hypertriglyceridaemia) | 15–25% | 20–35% | High (adjunct therapy) |
| ≥ 500 mg/dL | Very high (severe) | 25–35% | 30–50% | Very high (emergency pancreatitis prevention) |
Important: these values are averages from clinical studies. Individual responses may vary considerably — depending on lifestyle, diet, genetic predisposition and baseline levels.
EPA vs. DHA: Which Fatty Acid Is More Important for Triglycerides?
The scientific community has long debated whether EPA or DHA is more effective at lowering triglycerides — or whether both act equally. The current state of research:
EPA (Eicosapentaenoic Acid)
Pure EPA (as used in REDUCE-IT) shows particularly strong triglyceride reductions. EPA is preferentially used in the liver for regulating lipid metabolism. REDUCE-IT with pure icosapent ethyl (4 g/day EPA) showed 21% triglyceride reduction from baseline in high-risk patients.
DHA (Docosahexaenoic Acid)
DHA is also triglyceride-lowering, but in some studies tends to slightly raise LDL cholesterol — which should be considered when treating hypertriglyceridaemia. The increase in LDL-C under DHA is moderate and clinically acceptable in most contexts.
Combined EPA+DHA
Most commercially available preparations and supplements contain EPA and DHA in combination (typically 3:2 or 1:2 ratio). The EFSA health claim and AHA recommendation refer to combined EPA+DHA. For practical supplementation, combined preparations are well established and effective.
Omega-3 and the Effect on LDL Cholesterol
An important note for clinical practice: high-dose omega-3 preparations (particularly those containing DHA) may slightly increase LDL cholesterol in some individuals. This effect is documented in studies but is moderate. When VLDL particles are degraded, a slight redistribution towards LDL particles may occur.
When using high-dose omega-3 to lower triglycerides, LDL cholesterol should therefore be monitored regularly — especially in patients with already elevated LDL levels or known coronary artery disease. Pure EPA (without DHA) shows less pronounced LDL increase in studies, which was one reason for the specific use of icosapent ethyl in trials like REDUCE-IT.
Combination Therapy: Omega-3 and Statins
In clinical practice, omega-3 is frequently combined with statins. Statins are highly effective at lowering LDL but have a considerably weaker effect on triglycerides. Omega-3 ideally complements statins: it lowers triglycerides and has no negative effect on the LDL-lowering action of statins.
REDUCE-IT demonstrated that EPA (4 g/day) significantly reduces cardiovascular events in patients already taking statins (more on this in the article Omega-3 and Heart Health). The combination of statin + high-dose omega-3 is therefore recognised by several specialist societies as an evidence-based approach in high-risk patients with hypertriglyceridaemia.
Which Lifestyle Measures Enhance the Omega-3 Effect?
The triglyceride-lowering effect of omega-3 is amplified by accompanying dietary and lifestyle measures. The following factors raise triglycerides and should be reduced:
Sugar and Refined Carbohydrates
The strongest dietary driver of high triglyceride levels is high consumption of sugar, white flour, soft drinks and fruit juices. De novo lipogenesis from fructose is a particularly efficient pathway to triglyceride formation. Reducing these foods can lower triglycerides significantly more than omega-3 alone.
Alcohol
Alcohol directly increases hepatic triglyceride production. Even moderate alcohol consumption can significantly raise triglyceride levels. In hypertriglyceridaemia, guidelines recommend strong reduction or complete abstinence.
Physical Activity
Regular aerobic exercise (at least 150 minutes/week of moderate intensity) significantly lowers triglycerides through increased fatty acid oxidation in muscle and improved insulin sensitivity.
Weight Reduction
Excess weight is a common factor in hypertriglyceridaemia. Every kilogram of body weight lost measurably lowers triglycerides — making the combination of omega-3 and weight management particularly effective.
Practical Overview: How Much Omega-3 for Triglycerides?
| Goal | Recommended dose EPA+DHA | EFSA status | Note |
|---|---|---|---|
| Normal heart function (baseline) | 250 mg/day | EFSA Health Claim | Minimum supply |
| Normal triglyceride levels | 2,000 mg/day | EFSA Health Claim | Achievable with high-quality capsules |
| Normal blood pressure | 3,000 mg/day | EFSA Health Claim | Simultaneously fulfils triglyceride claim |
| Clinical hypertriglyceridaemia | 4,000 mg/day | FDA-approved (Rx) | Medical supervision only; 30–50% reduction |
Omega-3 and Triglycerides: What Matters When Choosing a Product
For triglyceride reduction, what matters is the actual amount of EPA+DHA per daily dose — not the total fish oil content on the packaging. Many cheap fish oil capsules contain only 30% EPA+DHA (e.g. 300 mg EPA+DHA in a 1-g capsule). To reach 2 g EPA+DHA with such preparations, you would need 6–7 capsules daily.
Concentrated preparations with 60–80% EPA+DHA allow a higher dosage in 2–3 capsules. Points to consider when buying:
- EPA+DHA content per capsule/serving clearly stated (not just "omega-3" or "fish oil")
- Product in triglyceride form (TG) shows better bioavailability than ethyl ester
- Third-party laboratory testing or IFOS certification as quality proof
- Oxidation protection through vitamin E (tocopherol) in the formulation
- Fresh smell without rancid notes
A detailed guide on correct dosage can be found in the article Omega-3 Dosage per Day.
Frequently Asked Questions
How quickly do triglycerides decrease with omega-3?
Measurable effects on triglyceride levels appear in studies after 4–8 weeks of regular intake. After 12 weeks, effects are generally stable and well measurable. Maximum benefit is reached with continuous intake over 3–6 months. For a reliable assessment, a fasting blood draw is recommended before and 8–12 weeks after starting supplementation.
Is 1,000 mg of omega-3 per day enough for triglycerides?
No. The EFSA health claim for normal triglyceride levels applies from 2,000 mg (2 g) EPA+DHA per day. At 1,000 mg, studies may show some positive trends but no consistent, clinically relevant reductions. For a clinically meaningful effect (20–30% reduction in hypertriglyceridaemia), 2–4 g/day EPA+DHA are necessary.
Can I take high-dose omega-3 long-term?
EFSA considers doses up to 5 g/day EPA+DHA safe for adults. The FDA recommends limiting EPA+DHA from supplements to 3 g/day; higher doses should be prescribed by a doctor. With long-term high-dose intake, regular blood lipid monitoring (including LDL) and consultation with a doctor is advisable — especially with anticoagulants.
Does omega-3 work for very high triglyceride levels (≥ 500 mg/dL)?
Yes — with very high triglyceride levels, high-dose omega-3 (4 g/day) shows the strongest percentage reductions: 30–50% according to the AHA Science Advisory. Triglyceride levels above 500 mg/dL carry a risk of pancreatitis that must be taken seriously medically. In this range, prescription omega-3 preparations (Vascepa, Lovaza) and medical supervision are required — no self-treatment with OTC supplements.
Are there interactions with cholesterol-lowering medications?
Omega-3 fatty acids can be taken alongside statins (e.g. atorvastatin, rosuvastatin) without known negative pharmacological interactions — this is well studied in clinical trials such as REDUCE-IT (all participants took statins). With fibrates (also triglyceride-lowering), the doctor should be informed as enhanced triglyceride reduction may occur. Always discuss anticoagulants with your doctor.
Further Articles
Elevated triglycerides often occur alongside other cardiovascular risk factors that are also influenced by omega-3:
- Omega-3 and Heart Health — EFSA health claim, REDUCE-IT trial and meta-analyses with 127,477 participants
- Omega-3 for High Blood Pressure — EFSA health claim from 3,000 mg/day, meta-analysis of 70 RCTs
- Omega-3 Dosage per Day — Which amount is right for whom?
Medical disclaimer
This article is for general information purposes only and does not replace medical advice. All health claims are based on EFSA-approved health claims and published studies. Elevated triglyceride levels are a medical finding category requiring medical diagnosis and care. Dietary supplements are not a substitute for a balanced diet, exercise or medically prescribed medication. For triglyceride levels above 500 mg/dL, medical treatment is urgently required.